Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-02-01 | Penser Access by Carnegie | Penser Access by Carnegie: Arcoma Group - 4 minutes by Penser | Pressreleaser | Visa Stäng |
|
||||
2024-01-30 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Arcoma - Carnegie Investment Bank - 30 jan 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-01-30 | Penser Access by Carnegie | Penser Access by Carnegie: Arcoma - Rekordstarkt Q4 skapar starkt momentum in i 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-01-29 | Arcoma | Bokslutskommuniké 2023 – REKORDSTARKT KVARTAL, NETTOOMSÄTTNINGEN ÖKAR MED 24%, EBITDA ÖKAR MED 134% (MAR) | Pressreleaser | Visa Stäng |
|
||||
2024-01-25 | Arcoma | Arcoma AB tidigarelägger publicering av delårsrapport för oktober-december 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-12-20 | Arcoma | Arcoma välkomnar ny ägarstruktur efter Sunstone Life Science Ventures försäljning av aktier | Pressreleaser | Visa Stäng |
|
||||
2023-11-30 | Arcoma | Arcoma byter likviditetsgarant och Certified Adviser till Carnegie Investment Bank AB (publ) | Pressreleaser | Visa Stäng |
|
||||
2023-11-17 | Arcoma | Valberedning utsedd inför årsstämma 2024 i Arcoma AB | Pressreleaser | Visa Stäng |
|
||||
2023-10-27 | Penser Access | Penser Access: Tillväxt och marginal i Q3 understryker skalbarhet - Acroma | Pressreleaser | Visa Stäng |
|
||||
2023-10-26 | Penser Access | Penser Access: Intervju med Arcoma - Erik Penser Bank - 26 oktober 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-10-26 | Arcoma | Kvartalsrapport Q3 2023 – Stark tillväxt och lönsamhet – Nettoomsättningen ökar med 24%, EBITDA ökar med 37% (MAR) | Pressreleaser | Visa Stäng |
|
||||
2023-08-18 | Penser Access | Penser Access: God tillväxt i normaliserat marknadsklimat - Arcoma | Pressreleaser | Visa Stäng |
|
||||
2023-08-17 | Arcoma | Kvartalsrapport Q2 2023 – Fortsatt tillväxt – Omsättningen ökar med 24% (MAR) | Pressreleaser | Visa Stäng |
|
||||
2023-07-05 | Arcoma | Tarik Cengiz utses till ny Global Sales Director och Jesper Lindroos blir ny COO. | Pressreleaser | Visa Stäng |
|
||||
2023-06-12 | Arcoma | Arcoma signs distribution agreement with Canon Korea Inc. | Pressreleaser | Visa Stäng |
|
||||
2023-05-17 | Arcoma | Kommuniké från årsstämma i Arcoma Aktiebolag den 17 maj 2023. | Pressreleaser | Visa Stäng |
|
||||
2023-05-03 | Arcoma | Arcoma AB has received certification according to MDR (MAR) | Pressreleaser | Visa Stäng |
Pressreleaser |
Arcoma AB has received certification according to MDR (MAR)2023-05-03 PRESSRELEASE Arcoma AB has received certification according to MDR (MAR) We are proud to announce that Arcoma AB has received certification according to MDR (regulation EU 2017/745). Arcoma’s product range of Precision i5 and Intuition are therefore fully compatible with the EU regulations for medical devices. The new EU regulations MDR, Medical Device Regulation, which began to be applied in 2021, is a comprehensive change to the regulations for medical devices. The requirement for MDR certification guarantees that the medical devices used in healthcare are safe. ”Certification according to the MDR is an incredibly important milestone for us, it is proof that our products are safe and live up to the high standards required for medical equipment. The certification is very important for us as a company, for our customers and not least for the patients’ safety”, says Henrik Blomdahl, Quality Manager Arcoma AB. ”I am really happy that the certification has gone through and would like to thank everyone in the organization led by Henrik who have contributed to this success,” says Mattias Leire, CEO Arcoma AB About Arcoma Arcoma, with long experience in the industry, is a leading provider of integrated digital X-ray systems with high quality and advanced technology. Arcoma’s products offer the latest digital imaging technology combined with technically advanced moving positioning systems and ergonomic Scandinavian design. Arcoma offers the customers complete, configurable and functional digital x-ray systems. The company’s products are sold through retailers as well as OEM customers and today there are over 3,500 of Arcoma’s X-ray systems installed worldwide. Arcoma is listed on Nasdaq First North. For more information about Arcoma, please visit www.arcoma.se For more information, please contact: Henrik Blomdahl, Manager Quality and Regulatory, henrik.blomdahl@arcoma.se , +46 470-706922. For more IR-related information and the possibility of pressrelease prenumeration, please visit our IR page: www.arcoma.se/about-us/investors/ This information is such information that Arcoma AB is obliged to publish in accordance with the EU Market Abuse Regulation (MAR). The information was submitted, through the CEO, for publication on May 3rd , 2023 at 10.20 PM. |
||||
2023-05-03 | Arcoma | Arcoma AB har erhållit certifiering enligt MDR (MAR) | Pressreleaser | Visa Stäng |
|
||||
2023-05-03 | Penser Access | Penser Access: Intervju med Arcoma - Erik Penser Bank - 3 maj 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-05-02 | Penser Access | Penser Access: Förlänger trend av stark tillväxt - Arcoma | Pressreleaser | Visa Stäng |
|
||||
2023-04-27 | Arcoma | Kvartalsrapport Q1 2023: Positivt momentum – nettoomsättningen ökar med 55% (MAR) | Pressreleaser | Visa Stäng |
|
||||
2023-04-26 | Arcoma | Arcoma receives order of 10 systems to Thailand | Pressreleaser | Visa Stäng |
|
||||
2023-04-13 | Arcoma | Kallelse till årsstämma i Arcoma Aktiebolag | Pressreleaser | Visa Stäng |
|
||||
2023-04-06 | Arcoma | Årsredovisning 2022 är nu publicerad | Pressreleaser | Visa Stäng |
|